Cited by

• Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer.

  Goyal J, Antonarakis ES. Goyal J, et al. Clin Med Insights Urol. 2013 Jul 10;2013(7):1-14. doi: 10.4137/CMU.S8337. Clin Med Insights Urol. 2013. PMID: 24482578 Free PMC article.
• Reply to: Gilligan T. Is there such a thing as cancer treatment that isn't worth its cost? The oncologist 2012;17:3-4.

  Graham DM, O'Reilly S. Graham DM, et al. Oncologist. 2013;18(1):e1. doi: 10.1634/theoncologist.2012-0245. Oncologist. 2013. PMID: 23355620 Free PMC article.
• Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients.

  Sharma MR, Karrison TG, Kell B, Wu K, Turcich M, Geary D, Kang SP, Takebe N, Graham RA, Maitland ML, Schilsky RL, Ratain MJ, Cohen EE. Sharma MR, et al. Clin Cancer Res. 2013 Jun 1;19(11):3059-67. doi: 10.1158/1078-0432.CCR-12-3829. Epub 2013 Apr 3. Clin Cancer Res. 2013. PMID: 23553850 Free PMC article. Clinical Trial.
• Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

  Gounder MM, Zer A, Tap WD, Salah S, Dickson MA, Gupta AA, Keohan ML, Loong HH, D'Angelo SP, Baker S, Condy M, Nyquist-Schultz K, Tanner L, Erinjeri JP, Jasmine FH, Friedlander S, Carlson R, Unger TJ, Saint-Martin JR, Rashal T, Ellis J, Kauffman M, Shacham S, Schwartz GK, Abdul Razak AR. Gounder MM, et al. J Clin Oncol. 2016 Sep 10;34(26):3166-74. doi: 10.1200/JCO.2016.67.6346. Epub 2016 Jul 25. J Clin Oncol. 2016. PMID: 27458288 Free PMC article. Clinical Trial.
• Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.

  Prasad V, Massey PR, Fojo T. Prasad V, et al. J Clin Oncol. 2014 May 20;32(15):1620-9. doi: 10.1200/JCO.2013.53.0204. Epub 2014 Apr 7. J Clin Oncol. 2014. PMID: 24711558 Free PMC article.